B-CELL NON HODGKIN LYMPHOMA
Clinical trials for B-CELL NON HODGKIN LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new B-CELL NON HODGKIN LYMPHOMA trials appear
Sign up with your email to follow new studies for B-CELL NON HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug N-803 tested to boost CAR T-Cell success in lymphoma patients
Disease control TerminatedThis early-phase study aimed to see if the drug N-803 is safe and tolerable for adults with B-cell non-Hodgkin lymphoma who had already received CAR T-cell therapy. Participants had to have responded to CAR T treatment. The study was withdrawn before enrolling anyone, so no resul…
Matched conditions: B-CELL NON HODGKIN LYMPHOMA
Phase: PHASE1 • Sponsor: University of Utah • Aim: Disease control
Last updated May 01, 2026 16:01 UTC
-
New combo therapy targets tough lymphoma cases
Disease control OngoingThis study tests a new treatment for people with a type of blood cancer called B-cell non-Hodgkin lymphoma that has come back or not responded to standard therapy. The treatment combines two advanced immune therapies: a bispecific antibody and CAR-T cells. The goal is to see if t…
Matched conditions: B-CELL NON HODGKIN LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 01, 2026 16:00 UTC
-
New combo therapy aims to boost lymphoma treatment
Disease control OngoingThis early-phase study tests whether adding the drug acalabrutinib to CAR T-cell therapy (axicabtagene ciloleucel) is safe and works better for people with certain B-cell lymphomas. About 23 adults whose lymphoma has returned or not responded to prior treatment will receive the c…
Matched conditions: B-CELL NON HODGKIN LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Apr 29, 2026 15:04 UTC
-
New hope to tame the storm: drug trial aims to shield patients from CAR-T's worst side effects
Disease control OngoingThis study is testing if a drug called anakinra can prevent or reduce severe brain-related side effects and dangerous immune reactions in adults receiving CAR-T cell therapy for certain B-cell cancers. The goal is to make this powerful cancer treatment safer by controlling its mo…
Matched conditions: B-CELL NON HODGKIN LYMPHOMA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Apr 29, 2026 15:01 UTC
-
Blood test may replace scans for lymphoma relapse detection
Knowledge-focused OngoingThis study looks at whether a simple blood test can find signs that aggressive B-cell Non-Hodgkin lymphoma has returned after chemotherapy, possibly earlier than CT scans. About 501 adults who have finished initial treatment will give blood samples to check for minimal residual d…
Matched conditions: B-CELL NON HODGKIN LYMPHOMA
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated May 01, 2026 16:00 UTC